Amphastar Pharmaceuticals, Inc. (AMPH)
20.58
-0.43
(-2.05%)
USD |
NASDAQ |
Mar 03, 11:18
Amphastar Pharmaceuticals Research and Development Expense (Annual) : 71.24M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |
| Organon & Co. | 366.00M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| CorMedix, Inc. | 3.942M |